AP2S1 and acute coronary syndrome: We demonstrated significant increase of levels of plasma apelinergic system peptides, especially ELA and AP-17 in acute coronary syndrome patients compared with healthy controls and chronic coronary syndromes, suggestive of compensating up-regulation mechanisms.